The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Orally Disintegrating Tablets-Global Market Insights and Sales Trends 2024

Orally Disintegrating Tablets-Global Market Insights and Sales Trends 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1851745

No of Pages : 106

Ask Your Query
Synopsis
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablets market size is expected to reach US$ 30610 million by 2029, growing at a CAGR of 11.7% from 2023 to 2029. The market is mainly driven by the significant applications of Orally Disintegrating Tablets in various end use industries. The expanding demands from the CNS Diseases, Gastrointestinal Diseases, CVS Diseases and Other, are propelling Orally Disintegrating Tablets market. Anti-Psychotics Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Epileptics Drug segment is estimated at % CAGR for the next seven-year period.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orally Disintegrating Tablets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orally Disintegrating Tablets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orally Disintegrating Tablets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orally Disintegrating Tablets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orally Disintegrating Tablets covered in this report include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company and AstraZeneca, etc.
The global Orally Disintegrating Tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Global Orally Disintegrating Tablets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orally Disintegrating Tablets market, Segment by Type:
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Global Orally Disintegrating Tablets market, by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Orally Disintegrating Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Orally Disintegrating Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Orally Disintegrating Tablets Market Overview
1.1 Orally Disintegrating Tablets Product Overview
1.2 Orally Disintegrating Tablets Market Segment by Type
1.2.1 Anti-Psychotics Drug
1.2.2 Anti-Epileptics Drug
1.2.3 Other
1.3 Global Orally Disintegrating Tablets Market Size by Type
1.3.1 Global Orally Disintegrating Tablets Market Size Overview by Type (2018-2029)
1.3.2 Global Orally Disintegrating Tablets Historic Market Size Review by Type (2018-2023)
1.3.3 Global Orally Disintegrating Tablets Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Orally Disintegrating Tablets Sales Breakdown by Type (2018-2023)
1.4.2 Europe Orally Disintegrating Tablets Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Orally Disintegrating Tablets Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Orally Disintegrating Tablets Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Orally Disintegrating Tablets Sales Breakdown by Type (2018-2023)
2 Global Orally Disintegrating Tablets Market Competition by Company
2.1 Global Top Players by Orally Disintegrating Tablets Sales (2018-2023)
2.2 Global Top Players by Orally Disintegrating Tablets Revenue (2018-2023)
2.3 Global Top Players by Orally Disintegrating Tablets Price (2018-2023)
2.4 Global Top Manufacturers Orally Disintegrating Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Orally Disintegrating Tablets Market Competitive Situation and Trends
2.5.1 Orally Disintegrating Tablets Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Orally Disintegrating Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orally Disintegrating Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Orally Disintegrating Tablets Market
2.8 Key Manufacturers Orally Disintegrating Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Orally Disintegrating Tablets Status and Outlook by Region
3.1 Global Orally Disintegrating Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Orally Disintegrating Tablets Historic Market Size by Region
3.2.1 Global Orally Disintegrating Tablets Sales in Volume by Region (2018-2023)
3.2.2 Global Orally Disintegrating Tablets Sales in Value by Region (2018-2023)
3.2.3 Global Orally Disintegrating Tablets Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Orally Disintegrating Tablets Forecasted Market Size by Region
3.3.1 Global Orally Disintegrating Tablets Sales in Volume by Region (2024-2029)
3.3.2 Global Orally Disintegrating Tablets Sales in Value by Region (2024-2029)
3.3.3 Global Orally Disintegrating Tablets Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Orally Disintegrating Tablets by Application
4.1 Orally Disintegrating Tablets Market Segment by Application
4.1.1 CNS Diseases
4.1.2 Gastrointestinal Diseases
4.1.3 CVS Diseases
4.1.4 Other
4.2 Global Orally Disintegrating Tablets Market Size by Application
4.2.1 Global Orally Disintegrating Tablets Market Size Overview by Application (2018-2029)
4.2.2 Global Orally Disintegrating Tablets Historic Market Size Review by Application (2018-2023)
4.2.3 Global Orally Disintegrating Tablets Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Orally Disintegrating Tablets Sales Breakdown by Application (2018-2023)
4.3.2 Europe Orally Disintegrating Tablets Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Orally Disintegrating Tablets Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Orally Disintegrating Tablets Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Orally Disintegrating Tablets Sales Breakdown by Application (2018-2023)
5 North America Orally Disintegrating Tablets by Country
5.1 North America Orally Disintegrating Tablets Historic Market Size by Country
5.1.1 North America Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Orally Disintegrating Tablets Sales in Volume by Country (2018-2023)
5.1.3 North America Orally Disintegrating Tablets Sales in Value by Country (2018-2023)
5.2 North America Orally Disintegrating Tablets Forecasted Market Size by Country
5.2.1 North America Orally Disintegrating Tablets Sales in Volume by Country (2024-2029)
5.2.2 North America Orally Disintegrating Tablets Sales in Value by Country (2024-2029)
6 Europe Orally Disintegrating Tablets by Country
6.1 Europe Orally Disintegrating Tablets Historic Market Size by Country
6.1.1 Europe Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Orally Disintegrating Tablets Sales in Volume by Country (2018-2023)
6.1.3 Europe Orally Disintegrating Tablets Sales in Value by Country (2018-2023)
6.2 Europe Orally Disintegrating Tablets Forecasted Market Size by Country
6.2.1 Europe Orally Disintegrating Tablets Sales in Volume by Country (2024-2029)
6.2.2 Europe Orally Disintegrating Tablets Sales in Value by Country (2024-2029)
7 Asia-Pacific Orally Disintegrating Tablets by Region
7.1 Asia-Pacific Orally Disintegrating Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Orally Disintegrating Tablets Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Orally Disintegrating Tablets Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Orally Disintegrating Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Orally Disintegrating Tablets Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Orally Disintegrating Tablets Sales in Value by Region (2024-2029)
8 Latin America Orally Disintegrating Tablets by Country
8.1 Latin America Orally Disintegrating Tablets Historic Market Size by Country
8.1.1 Latin America Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Orally Disintegrating Tablets Sales in Volume by Country (2018-2023)
8.1.3 Latin America Orally Disintegrating Tablets Sales in Value by Country (2018-2023)
8.2 Latin America Orally Disintegrating Tablets Forecasted Market Size by Country
8.2.1 Latin America Orally Disintegrating Tablets Sales in Volume by Country (2024-2029)
8.2.2 Latin America Orally Disintegrating Tablets Sales in Value by Country (2024-2029)
9 Middle East and Africa Orally Disintegrating Tablets by Country
9.1 Middle East and Africa Orally Disintegrating Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Orally Disintegrating Tablets Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Orally Disintegrating Tablets Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Orally Disintegrating Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Orally Disintegrating Tablets Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Orally Disintegrating Tablets Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Orally Disintegrating Tablets Products Offered
10.1.5 Teva Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Orally Disintegrating Tablets Products Offered
10.2.5 Merck Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Orally Disintegrating Tablets Products Offered
10.3.5 Mylan Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Orally Disintegrating Tablets Products Offered
10.4.5 Pfizer Recent Development
10.5 Johnson and Johnson
10.5.1 Johnson and Johnson Company Information
10.5.2 Johnson and Johnson Introduction and Business Overview
10.5.3 Johnson and Johnson Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson and Johnson Orally Disintegrating Tablets Products Offered
10.5.5 Johnson and Johnson Recent Development
10.6 GSK
10.6.1 GSK Company Information
10.6.2 GSK Introduction and Business Overview
10.6.3 GSK Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GSK Orally Disintegrating Tablets Products Offered
10.6.5 GSK Recent Development
10.7 Otsuka
10.7.1 Otsuka Company Information
10.7.2 Otsuka Introduction and Business Overview
10.7.3 Otsuka Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Otsuka Orally Disintegrating Tablets Products Offered
10.7.5 Otsuka Recent Development
10.8 Eli Lilly and Company
10.8.1 Eli Lilly and Company Company Information
10.8.2 Eli Lilly and Company Introduction and Business Overview
10.8.3 Eli Lilly and Company Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eli Lilly and Company Orally Disintegrating Tablets Products Offered
10.8.5 Eli Lilly and Company Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AstraZeneca Orally Disintegrating Tablets Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Bristol-Myers Squibb
10.10.1 Bristol-Myers Squibb Company Information
10.10.2 Bristol-Myers Squibb Introduction and Business Overview
10.10.3 Bristol-Myers Squibb Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bristol-Myers Squibb Orally Disintegrating Tablets Products Offered
10.10.5 Bristol-Myers Squibb Recent Development
10.11 Conquer
10.11.1 Conquer Company Information
10.11.2 Conquer Introduction and Business Overview
10.11.3 Conquer Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Conquer Orally Disintegrating Tablets Products Offered
10.11.5 Conquer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Orally Disintegrating Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Orally Disintegrating Tablets Industrial Chain Analysis
11.4 Orally Disintegrating Tablets Market Dynamics
11.4.1 Orally Disintegrating Tablets Industry Trends
11.4.2 Orally Disintegrating Tablets Market Drivers
11.4.3 Orally Disintegrating Tablets Market Challenges
11.4.4 Orally Disintegrating Tablets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Orally Disintegrating Tablets Distributors
12.3 Orally Disintegrating Tablets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock